<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37394863</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0578-1426</ISSN><JournalIssue CitedMedium="Print"><Volume>62</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Zhonghua nei ke za zhi</Title><ISOAbbreviation>Zhonghua Nei Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Progress in the application of uric acid-lowering treatments in amyotrophic lateral sclerosis].</ArticleTitle><Pagination><StartPage>885</StartPage><EndPage>890</EndPage><MedlinePgn>885-890</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112138-20220708-00498</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Y N</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>J Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>D S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Nei Ke Za Zhi</MedlineTA><NlmUniqueID>16210490R</NlmUniqueID><ISSNLinking>0578-1426</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>268B43MJ25</RegistryNumber><NameOfSubstance UI="D014527">Uric Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014527" MajorTopicYN="N">Uric Acid</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>&#x5c3f;&#x9178;&#x662f;&#x4eba;&#x4f53;&#x5185;&#x560c;&#x5464;&#x4ee3;&#x8c22;&#x7684;&#x7ec8;&#x4ea7;&#x7269;&#xff0c;&#x4e3b;&#x8981;&#x901a;&#x8fc7;&#x5f71;&#x54cd;&#x80fd;&#x91cf;&#x4ee3;&#x8c22;&#x3001;&#x6c27;&#x5316;&#x5e94;&#x6fc0;&#x3001;&#x708e;&#x75c7;&#x53cd;&#x5e94;&#x7b49;&#x901a;&#x8def;&#x6765;&#x5f71;&#x54cd;&#x808c;&#x840e;&#x7f29;&#x4fa7;&#x7d22;&#x786c;&#x5316;&#x75c7;&#xff08;ALS&#xff09;&#x7684;&#x53d1;&#x751f;&#x53d1;&#x5c55;&#xff0c;&#x4f46;&#x76ee;&#x524d;&#x5c3f;&#x9178;&#x5bf9;&#x4e8e;ALS&#x7684;&#x4f5c;&#x7528;&#x4ecd;&#x7136;&#x5b58;&#x5728;&#x4e89;&#x8bae;&#x3002;&#x52a8;&#x7269;&#x5b9e;&#x9a8c;&#x663e;&#x793a;&#x964d;&#x5c3f;&#x9178;&#x836f;&#x7269;&#x9ec4;&#x560c;&#x5464;&#x6c27;&#x5316;&#x9176;&#x6291;&#x5236;&#x5242;&#x53ef;&#x4ee5;&#x5ef6;&#x7f13;&#x52a8;&#x7269;&#x6a21;&#x578b;&#x53d1;&#x75c5;&#x3001;&#x5ef6;&#x957f;&#x751f;&#x5b58;&#x671f;&#x3001;&#x51cf;&#x7f13;&#x4f53;&#x91cd;&#x4e0b;&#x964d;&#x3001;&#x5ef6;&#x7f13;&#x8fd0;&#x52a8;&#x80fd;&#x529b;&#x4e0b;&#x964d;&#xff0c;&#x63d0;&#x793a;&#x964d;&#x5c3f;&#x9178;&#x836f;&#x7269;&#xff0c;&#x5c24;&#x5176;&#x662f;&#x9ec4;&#x560c;&#x5464;&#x9176;&#x6291;&#x5236;&#x5242;&#x5728;ALS&#x4e2d;&#x5e94;&#x7528;&#x7684;&#x6f5c;&#x5728;&#x53ef;&#x80fd;&#x6027;&#x3002;.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>2</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37394863</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112138-20220708-00498</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>